The Challenges of Fertility Preservation in Cancer Patients: An Interview with Michael Grynberg

Michaël Grynberg is an Obstetrician Gynecologist specialized in reproductive medicine. After 1 year as a visiting fellow in the Department of Reproductive Medicine at Cornell University, he returned to work in France as an Attending Physician in the Division of Reproductive Medicine at the University Hospital Antoine Béclère, Clamart, France. In 2011, he completed his PhD on the topic of the regulation of follicular growth and anti-Müllerian hormone production. Since 2014, he has been Professor of Reproductive Medicine and the Head of the Department of Reproductive Medicine and Fertility Preservation at the University Hospital Jean Verdier, Bondy, France. Since 2017, he has become the Head of the Department of Reproductive Medicine and Fertility Preservation at the University Hospital Antoine Béclère, Clamart, France. In addition, he is an active member of the basic research unit INSERM U 1133, University Paris Diderot-CNRS UMR 8251. His research interests initially include the assessment of ovarian follicular status and the regulation of anti-Müllerian hormone, a key peptide in the ovarian function. Over the past 5 years, he has expanded his field of research with oncofertility. Indeed, female fertility preservation has recently emerged in the field of reproductive medicine. He is a pioneer on this topic in France and has recently become the President of the French Society of Oncofertility. He, along with his colleagues, has published over 100 peer-reviewed articles in international journals and books.